4//SEC Filing
Puttagunta Sailaja 4
Accession 0001209191-22-059733
CIK 0001659323other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:00 PM ET
Size
9.6 KB
Accession
0001209191-22-059733
Insider Transaction Report
Form 4
Puttagunta Sailaja
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2022-12-01+8,334→ 8,334 total - Sale
Ordinary Shares
2022-12-02$1.32/sh−3,365$4,442→ 4,969 total - Exercise/Conversion
Restricted Share Units
2022-12-01−8,334→ 24,999 total→ Ordinary Shares (8,334 underlying)
Footnotes (5)
- [F1]On August 17, 2022, the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported on this Form 4 have been adjusted to reflect the Reverse Share Split
- [F2]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F3]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person.
- [F4]The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split.
- [F5]On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001792314
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:00 PM ET
- Size
- 9.6 KB